TY - JOUR
T1 - A scoping review of quality of life questionnaires in glaucoma patients
AU - the Educational Club of Ocular Surface and Glaucoma (ECOS-G)
AU - Gazzard, Gus
AU - Kolko, Miriam
AU - Iester, Michele
AU - Crabb, David P.
AU - Emesz, Martin
AU - Hirn, Cornelia
AU - Hommer, Anton
AU - Kaya, Semira
AU - Kellner, Lukas
AU - Lenzhofer, Markus
AU - Vass, Clemens
AU - Collignon, Natalie
AU - de Groot, Veva
AU - Duchesne, Bernard
AU - Kestelyn, Philippe
AU - Koppen, Carina
AU - Stalmans, Ingeborg
AU - Stevens, Anna Maria
AU - Samsonova, Bissera
AU - Zoric-Geber, Mia
AU - Knudsen, Lars Loumann
AU - Thygesen, John
AU - Setälä, Niko
AU - Vesti, Eija
AU - Baudouin, Christophe
AU - Chiambaretta, Frédéric
AU - Daien, Vincent
AU - Rousseau, Antoine
AU - Burk, Reinhard
AU - Erb, Carl
AU - Kaercher, Thomas
AU - Lanzl, Ines
AU - Messmer, Elisabeth
AU - Steven, Philipp
AU - Anastasopoulos, Eleftherios
AU - Boboridis, Konstadinos
AU - Katsanos, Andreas
AU - Kyroudis, Dimitris
AU - Topouzis, Fotis
AU - Murphy, Conor
AU - Aragona, Pasquale
AU - Traverso, Carlo Enrico
AU - Maldonado, Hannel
AU - Miranda, Arturo Ramirez
AU - Santacruz, Concepcion
AU - Ramos, Nalley
AU - Lemij, Hans
AU - Klyve, Per
AU - Raeder, Sten
AU - Misiuk-Hojlo, Marta
N1 - Publisher Copyright:
© 2021 The Author(s). Published by Wolters Kluwer Health, Inc. This is an open access article distributed under the terms of the Creative Commons Attribution-Non Commercial-No Derivatives License 4.0 (CCBY-NC-ND), where it is permissible to download and share the work provided it is properly cited. The work cannot be changed in any way or used commercially without permission from the journal.
PY - 2021/8/1
Y1 - 2021/8/1
N2 - Precis: Multiple questionnaires exist to measure glaucoma's impact on quality of life (QoL). Selecting the right questionnaire for the research question is essential, as is patients' acceptability of the questionnaire to enable collection of relevant patient-reported outcomes. Purpose: QoL relating to a disease and its treatment is an important dimension to capture. This scoping review sought to identify the questionnaires most appropriate for capturing the impact of glaucoma on QoL. Methods: A literature search of QoL questionnaires used in glaucoma, including patient-reported outcomes measures, was conducted and the identified questionnaires were analyzed using a developed quality criteria assessment. Results: Forty-one QoL questionnaires were found which were analyzed with the detailed quality criteria assessment leading to a summary score. This identified the top 10 scoring QoL questionnaires rated by a synthesis of the quality criteria grid, considering aspects such as reliability and reproducibility, and the authors' expert clinical opinion. The results were ratified in consultation with an international panel of ophthalmologists (N = 49) from the Educational Club of Ocular Surface and Glaucoma representing 23 countries. Conclusions: Wide variability among questionnaires used to determine vision related QoL in glaucoma and in the responses elicited was identified. In conclusion, no single existing QoL questionnaire design is suitable for all purposes in glaucoma research, rather we have identified the top 10 from which the questionnaire most appropriate to the study objective may be selected. Development of a new questionnaire that could better distinguish between treatments in terms of vision and treatment-related QoL would be useful that includes the patient perspective of treatment effects as well as meeting requirements of regulatory and health authorities. Future work could involve development of a formal weighting system with which to comprehensively assess the quality of QoL questionnaires used in glaucoma.
AB - Precis: Multiple questionnaires exist to measure glaucoma's impact on quality of life (QoL). Selecting the right questionnaire for the research question is essential, as is patients' acceptability of the questionnaire to enable collection of relevant patient-reported outcomes. Purpose: QoL relating to a disease and its treatment is an important dimension to capture. This scoping review sought to identify the questionnaires most appropriate for capturing the impact of glaucoma on QoL. Methods: A literature search of QoL questionnaires used in glaucoma, including patient-reported outcomes measures, was conducted and the identified questionnaires were analyzed using a developed quality criteria assessment. Results: Forty-one QoL questionnaires were found which were analyzed with the detailed quality criteria assessment leading to a summary score. This identified the top 10 scoring QoL questionnaires rated by a synthesis of the quality criteria grid, considering aspects such as reliability and reproducibility, and the authors' expert clinical opinion. The results were ratified in consultation with an international panel of ophthalmologists (N = 49) from the Educational Club of Ocular Surface and Glaucoma representing 23 countries. Conclusions: Wide variability among questionnaires used to determine vision related QoL in glaucoma and in the responses elicited was identified. In conclusion, no single existing QoL questionnaire design is suitable for all purposes in glaucoma research, rather we have identified the top 10 from which the questionnaire most appropriate to the study objective may be selected. Development of a new questionnaire that could better distinguish between treatments in terms of vision and treatment-related QoL would be useful that includes the patient perspective of treatment effects as well as meeting requirements of regulatory and health authorities. Future work could involve development of a formal weighting system with which to comprehensively assess the quality of QoL questionnaires used in glaucoma.
KW - Glaucoma
KW - Patient-reported outcomes measure
KW - Quality of life
KW - Questionnaire
KW - Treatment
U2 - 10.1097/IJG.0000000000001889
DO - 10.1097/IJG.0000000000001889
M3 - Review article
C2 - 34049352
AN - SCOPUS:85107439674
SN - 1057-0829
VL - 30
SP - 732
EP - 743
JO - Journal of Glaucoma
JF - Journal of Glaucoma
IS - 8
ER -